人体复活术:是医学的极致还是医学对哲学的挑战?  

Reversal of brain death:the prosperity of medicine or the medical challenge to philosophy?

作　　者：唐旭[1] 苟兴春[2] 徐礼鲜[3] 每晓鹏[3] 

机构地区：[1]四川中医药高等专科学校病理学教研室,四川绵阳621000 [2]西安医学院基础与转化医学研究所,陕西西安710021 [3]第四军医大学口腔医学院麻醉科,陕西西安710032

出　　处：《医学争鸣》2017年第1期15-18,23,共5页Negative

基　　金：国家自然科学基金(81471415;81271290)

摘　　要：据中外媒体报道,Bioquark和Revita Life Sciences两家美国公司即将利用干细胞移植等新兴医学技术,启动针对脑死亡者的人体复活术的第一次临床试验,并且该试验已得到美国和印度相关政府机构的批准。尽管现阶段干细胞移植等技术已经取得了令人瞩目的成就,但从生物医学的角度看,脑死亡者复活并无实现的可能;而站在哲学的立场,这一试验试图让脑死亡者起死回生的终极目标有违最基本的哲学规律,也不可能成功。同时,社会大众对这一试验的误解,可能导致盲目的科学主义的泛滥、医患关系的进一步恶化等社会问题。因此,哲学对科学的普遍指导功能和价值应该得到科学家的尊重;而媒体对类似科学研究的报道也应该秉持科学、严肃的态度。According to foreign and Chinese media reports, two US companies, Bioquark Inc. and Revita Life Sciences, announced a recent plan to undertake the first clinical trial to resurrect the clinically dead brain using stem cell transplantation techniques, which has been given permission by American and Indian governments. Although so Far biotechnologies such as stem cell therapy have made remarkable achievements, it is still impossible to bring the dead back to life in medicine, In addition, this trial goes against the basic law of philosophy and its final goal of reviving the dead is impossible to come true, Moreover, the public misunderstanding of this trial might lead to the emerging of scientism tendency and further deteriorate the doctor-patient relationship. Therefore, scientists should revere the general guidance function and value of philosophy, and media should report such scientific researches with a scientific and serious attitude.

关 键 词：脑死亡 复苏 干细胞疗法 哲学 

分 类 号：R741.05[医药卫生—神经病学与精神病学]